Nav: Home

Rare and common genetic variants combine to cause skull-fusion disorder

September 08, 2016

During the first year of life, the human brain doubles in size, and continues growing through adolescence. But sometimes, the loosely connected plates of a baby's skull fuse too early, a disorder known as craniosynostosis. Variants of this disorder can produce facial and skull deformities, and put potentially damaging constraints on a young brain.

A research team led by Rockefeller University President Richard P. Lifton, then at Yale University, has identified mutations responsible for a type of craniosynostosis that affects the suture running along the top of the skull. The results appear in eLife.

"While this discovery will immediately help us diagnose and counsel patients, it also has much broader relevance for understanding the genetics of complex traits, including many human diseases," says Lifton, who is head of Rockefeller's Laboratory of Human Genetics and Genomics and was a Howard Hughes Medical Institute investigator prior to moving to Rockefeller.

He and his team at Yale, including John Persing and colleagues in the Section of Plastic and Reconstructive Surgery, found that rare mutations in one gene collaborate with common variants near a second to cause midline craniosynostosis. As such, this disorder is a unique example of how an interaction between genes can contribute to disease.

Sporadic inheritance

Midline craniosynostosis occurs when the suture in front of or behind the soft spot atop a baby's skull closes early, producing a ridge or other distortions and, in some cases, neurological problems. First author Andrew Timberlake, an M.D.-Ph.D. student in Lifton's lab at Yale, used social media to recruit many of the 191 families who participated in this study.

By plotting out the inheritance of the disorder through the families, the team noticed that it showed up unpredictably within them. Clearly, they thought, something more than simple dominant or recessive inheritance was at play. When they sequenced the participants' protein-coding genes, or exomes, mutations in one gene, SMAD6, caught their attention. This made sense; SMAD6 is a protein that inhibits so-called BMP signaling, which promotes bone formation. But not everyone carrying these rare SMAD6 mutations had midline craniosynostosis. In fact, none of the parents who shared the SMAD6 mutation with their affected children had a history of craniosynostosis--a finding that initially surprised researchers.

A partner in crime

The team then looked to find mutations that might affect the same bone formation pathway. Some previous work implicated common changes near one such gene, BMP2, so they looked for these variations among the families.

"It was amazing to then find that the affected children had inherited both the SMAD6 mutation and the common BMP2 variant. In each case, the SMAD6 mutation came from one parent and the BMP2 risk variant came from the other parent, explaining why neither parent had craniosynostosis," Timberlake says.

The researchers believe that the risk variants near BMP2 increase the levels of the bone-promoting BMP signaling, thereby amplifying the effect of the loss of SMAD6's ability to inhibit the process. The result: The gap between the skull bones fuses ahead of schedule.

Among the families studied, those who carried the rare, damaging SMAD6 mutation plus a common BMP2 risk variant always had midline craniosynostosis, while those with only a SMAD6 mutation, but no BMP2 risk allele, were much less likely to suffer from the disorder. This knowledge should help doctors and genetic counselors better assess the risk within families.

New insight on disease risk

The researchers suggest that a similar dynamic may be at play in other rare genetic disorders that don't appear to follow classical Mendelian inheritance patterns.

"Our results offer a clear demonstration of the interaction between rare and common variants," Lifton says, "offering one explanation to a lingering question in genetics: Why do some individuals with potent rare mutations develop disease, while others with the same mutations do not?"
-end-
About The Rockefeller University

The Rockefeller University is the world's leading biomedical research university and is dedicated to conducting innovative, high-quality research to improve the understanding of life for the benefit of humanity. Our 79 laboratories conduct research in neuroscience, immunology, biochemistry, genomics, and many other areas, and a community of 1,800 faculty, students, postdocs, technicians, clinicians, and administrative personnel work on our 14-acre Manhattan campus. Our unique approach to science has led to some of the world's most revolutionary and transformative contributions to biology and medicine. During Rockefeller's 115-year history, 24 of our scientists have won Nobel Prizes, 21 have won Albert Lasker Medical Research Awards, and 20 have garnered the National Medal of Science, the highest science award given by the United States.

Rockefeller University

Related Genetics Articles:

Improve evolution education by teaching genetics first
Evolution is a difficult concept for many students at all levels, however, a study publishing on May 23 in the open access journal PLOS Biology has demonstrated a simple cost-free way to significantly improve students' understanding of evolution at the secondary level: teach genetics before you teach them evolution.
Study unravels the genetics of childhood 'overgrowth'
Researchers have undertaken the world's largest genetic study of childhood overgrowth syndromes -- providing new insights into their causes, and new recommendations for genetic testing.
Could genetics influence what we like to eat?
Gene variants could affect food preferences in healthy people, according to a new study.
Reverse genetics for rotavirus
Osaka University scientists generate a new plasmid-based reverse genetics system for rotaviruses.
The genetics behind being Not Like Daddy
A common strategy to create high-yielding plants is hybrid breeding.
Understanding the genetics of human height
A large-scale international study involving more than 300 researchers, published today in Nature, heralds the discovery of 83 genetic variations controlling human height.
Animal genetics: The bovine heritage of the yak
Though placid enough to be managed by humans, yaks are robust enough to survive at 4,000 meters altitude.
New genetics clues into motor neuron disease
Researchers at the University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease, opening the door for targeted treatments.
Your best diet might depend on your genetics
If you've ever seen a friend have good results from a diet but then not been able to match those results yourself, you may not be surprised by new findings in mice that show that diet response is highly individualized.
Using precision-genetics in pigs to beat cancer
Because of their similarities to people, using new technology in pigs turn up as a valuable alternative to rodent models of cancer.

Related Genetics Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...